Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update
— Total Company Revenues of $306.0 Million for the First Quarter of 2026— —BRINSUPRI® (brensocatib) Revenues of $207.9 Million for the First Quarter of 2026,...
— Total Company Revenues of $306.0 Million for the First Quarter of 2026— —BRINSUPRI® (brensocatib) Revenues of $207.9 Million for the First Quarter of 2026,...
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
